Marcel Botha, cofounder and CEO of 10XBeta, warns that President Trump's tariffs may jeopardize the quality and safety of medical innovations and hinder patient care.
The orchestrator includes customizable, multimodal AI agents to streamline oncology workflows like tumor boards and improve clinical decision-making.
The funds will be used to help the company expand into the employer and health plan markets and speed up the development of its AI technology for providers and members.
The company began trading on the NYSE today under the ticker symbol HNGE, opening at $39.25, up 23% from its IPO price of $32, and closing at $37.56 per share.
The funds will be used to support building a GMP system for long-acting injectables and grow the company's robotic lab.
MobiHealthNews examines the impact of automated dispensing cabinets, robotic surgery, AI in radiology and smart screens on patients' receiving and physicians' delivering care.
Layer Health's AI platform will be used to automate reporting and accelerate the chart review process.
